Sanofi Accelerates Flu Vaccine Production for 2025-26 Season, Aligning with FDA-Selected Strains

Sanofi announced the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and ...

March 17, 2025 | Monday | News
Autonomix Advances Sensing and RF Ablation System Toward U.S. Clinical Trials for Pancreatic Cancer Pain

Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency (“RF&rdq...

March 14, 2025 | Friday | News
QIAGEN Sues bioMérieux in German Patent Court to Protect QuantiFERON Technology

QIAGEN files lawsuit against bioMérieux with German Unified Patent Court to protect key innovations in its QuantiFERON technology Qua...

March 03, 2025 | Monday | News
Nxera Pharma Signs Agreement with Viatris and Idorsia for Cenerimod Development and Commercialization in Japan, South Korea, and APAC

Nxera Pharma has entered an assignment agreement with Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Pharmaceuticals Ltd (&...

February 28, 2025 | Friday | News
Convergent Therapeutics Announces Promising Clinical Trial Updates for CONV01-α at ASCO Genitourinary Cancers Symposium 2025

Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment o...

February 11, 2025 | Tuesday | News
NeuFit Revolutionizes Neurological Rehabilitation with Innovative NEUBIE Device

 NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and therapeutic technolo...

February 06, 2025 | Thursday | News
ALX Oncology to Host Virtual Event on Updated Data from ASPEN-06 Trial of Evorpacept in HER2-Positive Advanced Gastric Cancer

ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing ther...

January 23, 2025 | Thursday | News
Trump Administration Takes Bold Step to Withdraw U.S. from World Health Organization

  President Donald J. Trump has signed an executive order initiating the withdrawal of the United States from the World Health Organization (WHO). Th...

January 21, 2025 | Tuesday | News
Sanofi’s Opella Achieves FDA Approval to Initiate OTC Cialis Use Trial

Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned a...

January 21, 2025 | Tuesday | News
Junshi Biosciences Partners with LEO Pharma to Launch Toripalimab in Europe

Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...

January 21, 2025 | Tuesday | News
PharmAla Biotech Partners with Merhavim Mental Health Centre for Groundbreaking MDMA-Assisted Psychotherapy Trial

PharmAla Biotech Holdings Inc.  a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel deriv...

January 21, 2025 | Tuesday | News
Fermion and Simcere Partner to Advance Innovative SSTR4 Agonist for Pain Management in Greater China

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain ...

January 20, 2025 | Monday | News
Celltrion Unveils Innovative Drug Development Strategy at J.P. Morgan Healthcare Conference

Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company,  announced its innovative drug development strategy in the rigorous and cutti...

January 15, 2025 | Wednesday | News
Samsung Biologics CEO John Rim Highlights 2025 Growth Strategy at J.P. Morgan Healthcare Conference

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO),  announced its latest business achievements a...

January 15, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close